Avecho Biotechnology (ASX:AVE) Buyback Yield %: -2.60 (As of Jul. 11, 2026)


What is Avecho Biotechnology Buyback Yield %?

Avecho Biotechnology ASX:AVE Buyback Yield % is -2.60 as of Jul. 11, 2026. The stock has 2 warning signs investors should review. Among 742 Biotechnology companies, Avecho Biotechnology ranks better than 66.58% on this metric.

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Avecho Biotechnology's current buyback yield was -2.60%.

Avecho Biotechnology Buyback Yield % Historical Data

* Premium members only.

The historical data trend for Avecho Biotechnology's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Avecho Biotechnology Buyback Yield % Chart

Avecho Biotechnology Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Buyback Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -17.30 -0.01 -65.69 0.00 -7.00

Avecho Biotechnology Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Buyback Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -65.69 -57.34 0.00 0.00 -7.00

ASX:AVE vs VRTX, REGN, ALNY: Buyback Yield % Comparison

For the Biotechnology subindustry, Avecho Biotechnology's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Avecho Biotechnology Buyback Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Avecho Biotechnology's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Avecho Biotechnology's Buyback Yield % falls into.


Avecho Biotechnology Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Avecho Biotechnology's Buyback Yield for the fiscal year that ended in Dec. 2025 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (-0.187 + 2.5) / 33.061176
=-7.00%

Avecho Biotechnology's annualized Buyback Yield for the quarter that ended in Dec. 2025 is calculated as

Buyback Yield=Net Issuance of Stock(TTM) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) (TTM)** / Market Cap
=- (-0.187 + 2.5) / 33.061176
=-7.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

Frequently Asked Questions Learn more about Buyback Yield % →
What does a Buyback Yield % of -2.60 mean?
Avecho Biotechnology (ASX:AVE) has a Buyback Yield % of -2.60 as of Jul. 11, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Avecho Biotechnology and its competitors. According to the industry distribution chart, Avecho Biotechnology ranks #248 out of 742 companies in the Biotechnology industry, placing it in the top 33.4%.
Is Avecho Biotechnology's Buyback Yield % too high?
Avecho Biotechnology's current Buyback Yield % is -2.60. Based on the distribution chart, Avecho Biotechnology ranks #248 out of 742 companies in the Biotechnology industry, which is above the industry midpoint.
How does Avecho Biotechnology's Buyback Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Avecho Biotechnology ranks #248 out of 742 companies for Buyback Yield %. This puts Avecho Biotechnology in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Biotechnology company?
A good Buyback Yield % depends on the Biotechnology industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Avecho Biotechnology and its competitors. Avecho Biotechnology's current Buyback Yield % is -2.60. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Avecho Biotechnology stock overvalued right now?
Avecho Biotechnology (ASX:AVE) has a current Buyback Yield % of -2.60. The current Buyback Yield % is -2.60. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Avecho Biotechnology (ASX:AVE), the current Buyback Yield % is -2.60 as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Avecho Biotechnology Business Description

Other Exchanges OEZ:Germany
Address Unit A8, 2A Westall Road, Clayton, Melbourne, VIC, AUS, 3168
Avecho Biotechnology Ltd is a research-based biotechnology company engaged in the development, production, sales, and licensing of products incorporating its patented platform technology Tocopheryl Phosphate Mixture (TPM), for the pharmaceutical, skincare, and animal health and nutrition industries. Its segments include Production, Human Health, and other segments. The Production segment, which is the key revenue driver, manufactures and sells TPM and Vital ET for use in drug delivery and cosmetic formulations. The Human Health segment's portfolio covers the delivery of drugs through gels, injectables, and patches, including the conduct of research and development activities. It focuses on the development of patches, including TPM/Oxymorphone and TPM/Oxycodone.